BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 35 filers reported holding BRIDGEBIO PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,143,169 | +759.6% | 17,500,000 | +337.5% | 0.04% | +660.0% |
Q4 2022 | $1,529,044 | -9.7% | 4,000,000 | 0.0% | 0.01% | -28.6% |
Q3 2022 | $1,694,000 | +5.8% | 4,000,000 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $1,601,000 | -16.4% | 4,000,000 | 0.0% | 0.01% | -12.5% |
Q1 2022 | $1,915,000 | – | 4,000,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INHERENT GROUP, LP | 39,500,000 | $15,386,396 | 4.59% |
Athyrium Capital Management, LP | 20,000,000 | $7,753,900 | 3.26% |
Diameter Capital Partners LP | 43,287,000 | $16,786,915 | 2.61% |
Affinity Asset Advisors, LLC | 10,000,000 | $3,895,290 | 1.53% |
DeepCurrents Investment Group LLC | 39,355,000 | $14,590,746 | 0.57% |
BRAIDWELL LP | 42,294,000 | $16,151,021 | 0.54% |
Context Capital Management, LLC | 16,458 | $6,285 | 0.46% |
Aequim Alternative Investments LP | 31,000,000 | $11,838,125 | 0.32% |
ARISTEIA CAPITAL, L.L.C. | 40,816,000 | $15,586,610 | 0.31% |
ABSOLUTE INVESTMENT ADVISERS, LLC | 5,000,000 | $1,875,000 | 0.28% |